Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Gross Margin (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Gross Margin data on record, last reported at 57.11% in Q3 2025.

  • For Q3 2025, Gross Margin fell 88.0% year-over-year to 57.11%; the TTM value through Sep 2025 reached 57.1%, down 170.0%, while the annual FY2024 figure was 59.03%, 78.0% down from the prior year.
  • Gross Margin reached 57.11% in Q3 2025 per UTMD's latest filing, up from 56.21% in the prior quarter.
  • Across five years, Gross Margin topped out at 64.21% in Q3 2021 and bottomed at 56.21% in Q2 2025.
  • Average Gross Margin over 5 years is 60.21%, with a median of 60.15% recorded in 2023.
  • Peak YoY movement for Gross Margin: skyrocketed 543bps in 2021, then plummeted -434bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 62.82% in 2021, then decreased by -2bps to 61.34% in 2022, then fell by -6bps to 57.55% in 2023, then increased by 1bps to 58.12% in 2024, then decreased by -2bps to 57.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 57.11% in Q3 2025, 56.21% in Q2 2025, and 57.03% in Q1 2025.